Global and U.S. Smart Patient Wearables Market Report, Published by QY Research.

QY Research has released a comprehensive new market report on Smart Patient Wearables, refers to medical devices worn on the body to continuously monitor vital signs, physiological parameters, and activity levels. They combine sensors, connectivity, and software to provide real-time health insights for patients, clinicians, and caregivers.

Core Market Data

Global market size: USD 10 billion
CAGR (2024-2030): 15.6%
Average price: USD 200 per unit
Annual production: 50 million units
Gross margin: 40%
Production capacity: 65 million units

List of Main Players

Apple (NASDAQ: AAPL, USA)
Samsung (KRX: 005930, South Korea)
Fitbit (Google) (NASDAQ: GOOGL, USA)
Garmin (NASDAQ: GRMN, Switzerland)
Medtronic (NYSE: MDT, Ireland)
Abbott (NYSE: ABT, USA)
Dexcom (NASDAQ: DXCM, USA)
Omron Healthcare (TYO: 6645, Japan)
Philips (NYSE: PHG, Netherlands)
GE HealthCare (NYSE: GE, USA)
iRhythm (NASDAQ: IRTC, USA)
Biotricity (NASDAQ: BTCY, USA)
VitalConnect (Private, USA)
Biobeat (Private, Israel)
iHealth Labs (Private, USA)
Withings (Private, France)
AliveCor (Private, USA)

1. By Product Type

Heart Rate / ECG
Blood Oxygen (SpO2)
Blood Pressure
Blood Glucose (CGM)
Activity, Motion & Sleep
Others

2. by Device Form

Smartwatches & Bands
Smart Patches
Smart Rings
Smart Clothing / Garments
Others

3. By Monitoring Parameter

Cardiac - heart rate, ECG, arrhythmia detection
Metabolic - glucose monitoring, insulin tracking
Respiratory - oxygen saturation, respiratory rate
Vital Signs & Activity - blood pressure, temperature, activity, sleep, posture

4. By Application

Home Care Wearables
Hospital/Clinical Wearables
Ambulatory/Remote Patient Monitoring (RPM)

Case Study for Bidding

Time: Q3 2025
Supplier: Dexcom, Inc. (NASDAQ: DXCM, USA)
Buyer: ABC Regional Health Authority, USA
Product: Continuous Glucose Monitoring (CGM) Wearable Device - Dexcom G7
Quantity: 5,000 units
Contract Value: USD 4,500,000
Delivery Timeline: 3 months from order confirmation

Case Study for End Using

End User: Patients with Type 2 Diabetes enrolled in remote monitoring program

Application: Continuous glucose monitoring (CGM) using wearable devices to track blood sugar levels in real-time, provide alerts for hypo- and hyperglycemia, and transmit data to healthcare providers for remote care management.

Installation Location / Usage Stage

Installation Location: Worn directly on the patient's body (wrist, chest, or arm patch), used at home or in outpatient settings.
Usage Stage: Continuous monitoring during daily activities, post-operative recovery, or chronic disease management; data is transmitted in real-time to healthcare providers for analysis and intervention.

Purpose

Continuous Health Monitoring: Track vital signs and physiological parameters in real-time to detect abnormalities early.
Remote Patient Management: Enable clinicians to monitor patients outside the hospital, reducing the need for frequent in-person visits.
Chronic Disease Support & Prevention: Assist patients with conditions like diabetes, cardiac issues, or respiratory disorders in managing their health proactively.

Effect

Improved Patient Outcomes: Early detection of anomalies allows timely intervention, reducing complications and hospitalizations.
Enhanced Care Efficiency: Remote monitoring decreases clinic visits and optimizes healthcare resources.
Patient Empowerment: Provides patients with real-time insights into their health, encouraging proactive self-management and adherence to treatment plans.

Alternative Technologies

Traditional Hospital-Based Monitoring: In-clinic vital signs checks using bedside monitors and manual measurements.
Home Medical Devices: Standalone devices like blood pressure cuffs, glucometers, and pulse oximeters without connectivity or continuous monitoring.
Telehealth Platforms without Wearables: Remote consultations using patient-reported data or periodic check-ins via phone or video, lacking real-time automated monitoring.

Therefore, Smart Patient Wearables remain a highly efficient tool for continuous health monitoring, enabling early detection of medical issues, supporting remote patient management, improving chronic disease outcomes, reducing hospital visits, and empowering patients with real-time insights for proactive self-care.

About QY Research

QY Research has established close partnerships with over 71,000 global leading players. With more than 20,000 industry experts worldwide, we maintain a strong global network to efficiently gather insights and raw data.

Our 36-step verification system ensures the reliability and quality of our data. With over 2 million reports, we have become the world's largest market report vendor. Our global database spans more than 2,000 sources and covers data from most countries, including import and export details.

We have partners in over 160 countries, providing comprehensive coverage of both sales and research networks. A 90% client return rate and long-term cooperation with key partners demonstrate the high level of service and quality QY Research delivers.

More than 30 IPOs and over 5,000 global media outlets and major corporations have used our data, solidifying QY Research as a global leader in data supply. We are committed to delivering services that exceed both client and societal expectations.

For Inquiries:

USA: +1-626-295-2442

Canada: +1-778-907-6631

China: +86-150-1303-8387

Japan: +81-90-3800-9273

South Korea: +82-2883-1278

India: +91-866-9986-909

Indonesia: +62-818-510-991

Germany: +49-15788468916

Switzerland: +41-765899438

Portugal: +351-910983247

Email: global@qyresearch.com

www.qyresearch.com

This release was published on openPR.